Actively Recruiting
Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease
Led by Children's Hospital Los Angeles · Updated on 2026-05-06
66
Participants Needed
1
Research Sites
221 weeks
Total Duration
On this page
Sponsors
C
Children's Hospital Los Angeles
Lead Sponsor
U
University of Southern California & Children's Hospital Los Angeles (USC-CHLA)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The current study seeks to build on previous research that demonstrates the efficacy of Acceptance and Commitment Therapy in combating stigma by investigating the feasibility and acceptability of a protocol to support Black adolescents and young adults in coping with race related stress. The study will consist of a small, purposeful, non-randomized sample (N = 30) of clients enrolled into a 10-session Acceptance and Commitment Therapy group. The group will be offered as part of regular clinical care at the Division of Adolescent and Young Adult Medicine. Three consecutive groups will be run with approximately 8-10 participants in each group over the next year.
CONDITIONS
Official Title
Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be an adolescent or young adult aged 14 to 21 years
- Have sickle cell disease
- Willing to enroll in the Acceptance and Commitment Therapy (ACT) group at the Division of Adolescent and Young Adult Medicine/Department of Hematology and Oncology
- Can be active, waitlisted, or new patients at CHLA
- Able to understand and speak English
- Have an English-speaking parent or guardian
- Able to provide consent or assent
- If pregnant, able to provide consent
- Developmentally typical
- Have a stable internet connection with webcam access and a private space for group sessions
- Agree to audio and video recording of the initial interview
- Agree to attend 6 weekly ACT group sessions
- Willing to participate as a member of the community advisory board (CAB) if selected
You will not qualify if you...
- Prisoners or youth in detention centers
- Unable to understand or speak English
- Do not have sickle cell disease
- At significant risk for suicide or self-injury
- Adolescents with families requiring frequent intervention from the Department of Children and Family Services
- Currently experiencing psychosis
- Have severe health concerns impacting participation or attendance
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Children's Hospital Los Angeles
Los Angeles, California, United States, 90027
Actively Recruiting
Research Team
X
Xzania Lee, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here